Challenging the two-minute tidal breathing challenge test

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 26, Issue 6, 2013, Pages 380-386

  Lexmond, Anne J ^a   Hagedoorn, Paul ^a   Frijlink, Henderik W ^a   De Boer, Anne H ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Adenosine 5 monophosphate; Bronchial challenge; Bronchial hyperresponsiveness; Challenge methods; Nebulization

Indexed keywords

ADENOSINE PHOSPHATE; METHACHOLINE;

AEROSOL; ARTICLE; CONTROLLED STUDY; EVAPORATION; FLOW RATE; HUMAN; NEBULIZATION; NEBULIZER; PEAK INSPIRATORY FLOW; PRACTICE GUIDELINE; PROVOCATION TEST; TWO MINUTE TIDAL BREATHING CHALLENGE TEST;

ADENOSINE MONOPHOSPHATE; ADMINISTRATION, INHALATION; AEROSOLS; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTION; BRONCHOCONSTRICTOR AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EQUIPMENT DESIGN; HUMANS; METHACHOLINE CHLORIDE; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; PREDICTIVE VALUE OF TESTS; PRESSURE; TIME FACTORS;

EID: 84884541856     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2012.1021     Document Type: Article

References (31)

1. Cockcroft DW: Bronchoprovocation methods: direct challenges. Clin Rev Allergy Immunol. 2003;24:19-26. (Pubitemid 36324078)
2. Van den Berge M, Meijer RJ, Kerstjens HAM, De Reus DM, Koeter GH, Kauffman HF, and Postma DS: PC20 adenosine 5-monophosphate is more closely associated with airway inflammation in asthma than PC20 methacholine. Am J Respir Crit Care Med. 2001;163:1546-1550. (Pubitemid 32578753)
3. De Meer G, Heederik D, and Postma DS: Bronchial responsiveness to adenosine 5-monophosphate (AMP) and methacholine differ in their relationship with airway allergy and baseline FEV1. Am J Respir Crit Care Med. 2002;165: 327-331. (Pubitemid 34118503)
4. Cushley MJ, Tattersfield AE, and Holgate ST: Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br J Clin Pharmacol. 1983;15: 161-165. (Pubitemid 13184390)
5. Mann JS, Holgate ST, Renwick AG, and Cushley MJ: Airway effects of purine nucleosides and nucleotides and release with bronchial provocation in asthma. J Appl Physiol. 1986; 61:1667-1676. (Pubitemid 17196218)
6. Phillips GD, Rafferty P, Beasley R, and Holgate ST: Effect of oral terfenadine on the bronchoconstrictor response to inhaled histamine and adenosine 5-monophosphate in nonatopic asthma. Thorax. 1987;42:939-945. (Pubitemid 18030872)
7. Van Velzen E, Van den Bos JW, Benckhuijsen JAW, Van Essel T, De Bruijn R, and Aalbers R: Effect of allergen avoidance at high altitude on direct and indirect bronchial hyperresponsiveness and markers of inflammation in children with allergic asthma. Thorax. 1996;51:582-584. (Pubitemid 26226510)
8. Tan KS, McFarlane LC, and Lipworth BJ: Loss of normal cyclical b2 adrenoceptor regulation and increased premenstrual responsiveness to adenosine monophosphate in stable female asthmatic patients. Thorax. 1997;52:608-611. (Pubitemid 27342208)
9. Van den Berge M, Kerstjens HAM, De Reus DM, Koëter GH, Kauffman HF, and Postma DS: Provocation with adenosine 5-monophosphate, but not methacholine, induces sputum eosinophilia. Clin Exp Allergy. 2004;34:71-76. (Pubitemid 38183683)
10. Prieto L, Reig I, Rojas R, Ferrer A, and Domenech J: The effect of challenge method on sensitivity and reactivity to adenosine 5-monophosphate in subjects with suspected asthma. Chest. 2006;130:1448-1453. (Pubitemid 44786739)
11. Aalbers R, Boorsma M, van der Woude H, and Jonkers R: Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study. Respir Res. 2010; 11:66.
12. Polosa R, Holgate ST, and Church MK: Adenosine as a proinflammatory mediator in asthma. Pulm Pharmacol. 1989; 2:21-26.
13. Cockcroft DW, Killian DN, Mellon JJA, and Hargreave FE: Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy. 1977;7:235-243. (Pubitemid 8159924)
14. Juniper EF, Frith PA, Dunnett C, Cockcroft DW, and Hargreave FE: Reproducibility and comparison of responses to inhaled histamine and methacholine. Thorax. 1978;33:705-710. (Pubitemid 9106424)
15. Sterk PJ, Fabbri LM, Quanjer PH, Cockcroft DW, O'Byrne PM, Anderson SD, Juniper EF, and Malo JL: Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993;16:53-83.
16. Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, MacIntyre NR, McKay RT, Wanger JS, Anderson SD, Cockcroft DW, Fish JE, and Sterk PJ: Guidelines for methacholine and exercise challenge testing-1999. Am J Respir Crit Care Med. 2000;161:309-329. (Pubitemid 30055941)
17. Joos GF, O'Connor B, Anderson SD, Chung F, Cockcroft DW, Dahlén B, DiMaria G, Foresi A, Hargreave FE, Holgate ST, Inman M, Lötvall J, Magnussen H, Polosa R, Postma DS, and Riedler J; ERS Task Force: Indirect airway challenges. Eur Respir J. 2003;21:1050-1068. (Pubitemid 36675625)
18. Denyer J, Dyche A, and Nikander K: Breathing patterns in adult patients. J Aerosol Med. 1997;10;P99.
19. De Boer AH, Gjaltema D, Hagedoorn P, Schaller M, Witt W, and Frijlink HW: Design and application of a new modular adapter for laser diffraction characterization of inhalation aerosols. Int J Pharm. 2002;249:233-245. (Pubitemid 35333449)
20. De Boer AH, Hagedoorn P, and Frijlink HW: The choice of a compressor for the aerosolisation of tobramycin (TOBI) with the PARI LC PLUS reusable nebuliser. Int J Pharm. 2003;268:59-69. (Pubitemid 37487823)
21. Brand P, Friemel I, Meyer T, Schulz H, Heyder J, and Häubinger K: Total deposition of therapeutic particles during spontaneous and controlled inhalations. J Pharm Sci. 2000;89:724-731.
22. Praml G, Scharrer E, De la Motte D, Nowak D, Scheuch G, Sommerer K, and Radon K: The physical and biological doses of methacholine are different for Mefar MB3 and Jaeger APS sidestream nebulizers. Chest. 2005;128:3585-3589. (Pubitemid 41698697)
23. Schulze J, Rosewich M, Riemer C, Dressler M, Rose MA, and Zielen S: Methacholine challenge-comparison of an ATS protocol to a new rapid single concentration technique. Respir Med. 2009;103:1898-1903.
24. Newman SP, Pellow PGD, and Clarke SW: Droplet size distributions of nebulised aerosols for inhalation therapy. Clin Phys Physiol Meas. 1986;7:139-146. (Pubitemid 16017978)
25. Niven RW, and Brain JD: Some functional aspects of air-jet nebulizers. Int J Pharm. 1994;104:73-85. (Pubitemid 24081022)
26. McCallion ON, Taylor KM, Thomas M, and Taylor AJ: Nebulization of fluids of different physicochemical properties with air-jet and ultrasonic nebulizers. Pharm Res. 1995; 12:1682-1688. (Pubitemid 26004694)
27. MacNeish CF, Coates AL, Meisner D, Thibert R, Kelemen S, and Vadas EB: A comparison of pulmonary availability between Ventolin (albuterol) nebules and Ventolin (albuterol) respirator solution. Chest. 1997;111:204-208. (Pubitemid 27043631)
28. Coates AL, MacNeish CF, Meisner D, Kelemen S, Thibert R, MacDonald J, and Vadas EB: The choice of jet nebulizer, nebulizing flow, and addition of albuterol affects the output of tobramycin aerosols. Chest. 1997;111:1206-1212. (Pubitemid 27200073)
29. Le Brun PPH, de Boer AH, Gjaltema D, Hagedoorn P, Heijerman HGM, and Frijlink HW: Inhalation of tobramycin in cystic fibrosis: Part 2: Optimization of the tobramycin solution for a jet and an ultrasonic nebulizer. Int J Pharm. 1999; 189:215-225. (Pubitemid 29481757)
30. Cockcroft DW, Hurst TS, and Gore BP: Importance of evaporative water losses during standardized nebulized inhalation provocation tests. Chest. 1989;96:505-508. (Pubitemid 19230368)
31. Usmani OS, Biddiscombe MF, and Barnes PJ: Regional lung deposition and bronchodilator response as a function of b2-agonist particle size. Am J Respir Crit Care Med. 2005;172:1497-1504. (Pubitemid 43076536)